Phillip A. Patten

Maxygen (United States)

Papers

1

Total Citations

111

H-Index

1

About

Phillip A. Patten has made transformative contributions to the field of protein engineering, with a particular focus on directed evolution and its application to therapeutic proteins. His most-cited work, "Advances in directed protein evolution by recursive genetic recombination: applications to therapeutic proteins" (2001, 111 citations), pioneered recursive genetic recombination strategies that dramatically improved the efficiency and scope of protein optimization. Patten’s research fundamentally advanced the ability to evolve proteins with enhanced stability, binding affinity, and therapeutic efficacy, bridging fundamental molecular biology with practical drug development. His innovations have enabled the creation of more effective biologics, impacting areas from antibody engineering to enzyme replacement therapies. With over a hundred citations on his landmark paper alone, Patten’s work continues to influence both academic researchers and biotech industries seeking to harness evolutionary principles for protein design. His contributions stand as a cornerstone in the rational engineering of biomolecules, inspiring new generations of scientists to explore the power of directed evolution in solving biomedical challenges.

Research Focus

Key Achievements

1
H-Index
1
Papers
111
Total Citations
111
Avg Citations/Paper
🏆 Most Cited Paper
Advances in directed protein evolution by recursive genetic recombination: applications to therapeutic proteins
111 citations · 2001
📈 Most Prolific Year: 2001 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Maxygen (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago